Richard Penly, MD
Family Medicine · Vero Beach, FLNPI 1194782185
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $691 of the $810 with a category attached, or 85.3%. It is spread thinly across 18 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $424 and has fallen 97.3% since, to $11 in 2021.
Across 40 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$182
- Amarin Pharma, Inc.$132
- Boehringer Ingelheim$88
- Tosoh Bioscience, Inc.$50
- Pfizer$49
- Abbott$42
- plus $266 from 12 others
What the payments were for
- Food & beverage$69185%
- Education$698%
- Gifts$506%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 9 | $182 |
| Amarin Pharma, Inc. | 8 | $132 |
| Boehringer Ingelheim | 2 | $88 |
| Tosoh Bioscience, Inc. | 1 | $50 |
| Pfizer | 3 | $49 |
| Abbott | 2 | $42 |
| Novo Nordisk | 2 | $38 |
| AbbVie | 2 | $35 |
| Merck | 2 | $30 |
| Bioventus LLC | 1 | $25 |
| Johnson & Johnson | 1 | $22 |
| GSK | 1 | $20 |
| Seqirus USA Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Amgen | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Astellas Pharma US Inc | 1 | $11 |
How this compares
$810 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Vero Beach
- Hal BrownVero Beach$477K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.